Amanote Research
Register
Sign In
Predictive Value of Gene Polymorphisms on Recurrence After the Withdrawal of Antithyroid Drugs in Patients With Graves’ Disease
Frontiers in Endocrinology
- Switzerland
doi 10.3389/fendo.2017.00258
Full Text
Open PDF
Abstract
Available in
full text
Categories
Endocrinology
Metabolism
Diabetes
Date
September 29, 2017
Authors
Jia Liu
Jing Fu
Yan Duan
Guang Wang
Publisher
Frontiers Media SA
Related search
Is Radioiodine More Likely Than Antithyroid Drugs to Worsen Ophthalmopathy in Patients With Graves Disease?
Nature Clinical Practice Endocrinology & Metabolism
The Predictive Value of Germline Polymorphisms in Patients With NSCLC
Journal of Cancer Therapy
Unfavourable Effect of Prolonged Treatment With Antithyroid Drugs on Radioiodine Therapy Outcome in Graves' Hyperthyroidism
Timocki medicinski glasnik
Hypothyroidism as a Late Sequela in Patients With Graves' Disease Treated With Antithyroid Agents
Journal of Clinical Investigation
Medicine
Influence of Total Thyroidectomy on Orbital Opthalmopathy and Levels of Antithyroid Antibodies in Patients With Graves' Disease
Polski Przeglad Chirurgiczny
Medicine
Surgery
Quality of Life Is Worse at 6-10 Years After Radioactive Iodine Treatment of Graves’ Disease as Compared With Antithyroid Drugs or Surgery
Clinical Thyroidology
Thyroid‐stimulating Hormone Receptor Antibodies During Follow‐up as Remission Markers in Childhood‐onset Graves' Disease Treated With Antithyroid Drugs
Kaohsiung Journal of Medical Sciences
Medicine
Primary Immune Thrombocytopenia Responding to Antithyroid Treatment in a Patient With Graves’ Disease
Annals of Hematology
Medicine
Hematology
RNASET2 ,GPR174 , and PTPN22 Gene Polymorphisms Are Related to the Risk of Liver Damage Associated With the Hyperthyroidism in Patients With Graves’ Disease
Journal of Clinical Laboratory Analysis
Allergy
Immunology
Biochemistry
Public Health
Medical Laboratory Technology
Clinical Biochemistry
Hematology
Microbiology
Environmental
Occupational Health
